Table 1.
Demographic characteristics at baseline (all participants).
| Group 1 (N = 270) | Group 2 (N = 85) | All participants (N = 355) | |
|---|---|---|---|
| Sex (n [%]) | |||
| Male | 133 (49.3) | 50 (58.8) | 183 (51.5) |
| Female | 137 (50.7) | 35 (41.2) | 172 (48.5) |
| Sex ratio: Male/Female | 0.97 | 1.43 | 1.06 |
| Age at baseline (years) | |||
| Mean (SD) | 1.6 (0.1) | 9.8 (3.4) | 3.5 (3.9) |
| Minimum; Maximum | 1.2; 1.9 | 2.9; 15.0 | 1.2; 15.0 |
| Median | 1.5 | 9.4 | 1.6 |
| Q1; Q3 | 1.5; 1.6 | 6.8; 13.1 | 1.5; 1.9 |
N: number of participants in group
n: number of participants
SD: standard deviation
Q1; Q3: first quartile; third quartile
Group 1: infants and toddlers < 2 years) who received 2 injections of Avaxim® 80U Pediatric vaccine
Group 2: children (aged 2 to 11 years) and adolescents (aged > 12 years) who received 2 injections of Avaxim® 80U Pediatric vaccine